KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CRISPR Therapeutics AG (CRSP) Asset Utilization Ratio (2016 - 2025)

CRISPR Therapeutics AG (CRSP) has disclosed Asset Utilization Ratio for 10 consecutive years, with 0.0 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 90.62% to 0.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0 through Dec 2025, down 90.62% year-over-year, with the annual reading at 0.0 for FY2025, 90.67% down from the prior year.
  • Asset Utilization Ratio hit 0.0 in Q4 2025 for CRISPR Therapeutics AG, down from 0.02 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.37 in Q2 2021 to a low of 0.0 in Q4 2022.
  • Historically, Asset Utilization Ratio has averaged 0.11 across 5 years, with a median of 0.06 in 2023.
  • Biggest five-year swings in Asset Utilization Ratio: surged 75541.13% in 2021 and later tumbled 99.84% in 2022.
  • Year by year, Asset Utilization Ratio stood at 0.33 in 2021, then crashed by 99.84% to 0.0 in 2022, then soared by 32895.55% to 0.17 in 2023, then plummeted by 90.35% to 0.02 in 2024, then plummeted by 90.62% to 0.0 in 2025.
  • Business Quant data shows Asset Utilization Ratio for CRSP at 0.0 in Q4 2025, 0.02 in Q3 2025, and 0.02 in Q2 2025.